Scarica l'app Stockscreener
1.58
2.47%
-0.04
Dopo l'orario di chiusura:
1.59
0.01
+0.63%
Precedente Chiudi:
$1.62
Aprire:
$1.62
Volume 24 ore:
71,013
Relative Volume:
0.33
Capitalizzazione di mercato:
$41.56M
Reddito:
$9.06M
Utile/perdita netta:
$-50.39M
Rapporto P/E:
-0.8229
EPS:
-1.92
Flusso di cassa netto:
$5.89M
1 W Prestazione:
+2.60%
1M Prestazione:
+1.94%
6M Prestazione:
+39.82%
1 anno Prestazione:
-3.66%
Intervallo 1D:
$1.56
$1.63
Intervallo di 1 settimana:
$1.54
$1.64
Portata 52W:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
Nome
Lava Therapeutics Nv
Settore
Industria
Telefono
31 6 3000 3035
Indirizzo
YALELAAN 62, UTRECHT
Confronta LVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.58 | 42.61M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-19 | Iniziato | JP Morgan | Overweight |
| 2021-04-19 | Iniziato | Jefferies | Buy |
| 2021-04-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Lava Therapeutics Nv Borsa (LVTX) Ultime notizie
Is LAVA Therapeutics N.V. forming a reversal patternLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Is LAVA Therapeutics N.V. (4PKB) stock overpriced at current multiplesJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Why LAVA Therapeutics N.V. stock remains resilientTrade Signal Summary & High Win Rate Trade Tips - newser.com
Published on: 2025-10-05 06:23:52 - newser.com
Analyzing recovery setups for LAVA Therapeutics N.V. investorsJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Measuring LAVA Therapeutics N.V.’s beta against major indicesQuarterly Trade Report & High Conviction Investment Ideas - newser.com
Will LAVA Therapeutics N.V. outperform the marketJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
What candlestick patterns are forming on LAVA Therapeutics N.V.Weekly Trend Recap & Daily Oversold Bounce Ideas - newser.com
How LAVA Therapeutics N.V. stock performs in rate cut cyclesJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Shay Capital LLC Acquires Significant Stake in LAVA Therapeutics NV - GuruFocus
LAVA Therapeutics Extends Tender Offer Deadline - TipRanks
XOMA Royalty extends tender offer deadline for LAVA Therapeutics By Investing.com - Investing.com Australia
XOMA Royalty extends tender offer deadline for LAVA Therapeutics - Investing.com India
XOMA Royalty Corporation Extends Tender Offer for LAVA Therapeutics Shares Until October 17, 2025 - Quiver Quantitative
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - GlobeNewswire
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - Benzinga
75% CVR: XOMA Royalty Extends Tender Offer for LAVA, Extended to Oct. 17 - Stock Titan
What drives LAVA Therapeutics NV stock priceBollinger Bands Signals & High-Risk, High-Reward? We Find the Winners - earlytimes.in
LAVA Therapeutics Postpones EGM for XOMA Deal - MSN
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - GlobeNewswire
LAVA Therapeutics Cancels Extraordinary General Meeting to Finalize XOMA Royalty Acquisition Details - Quiver Quantitative
Biotech Deal Update: LAVA Therapeutics Postpones XOMA Acquisition Vote to Address Cash Position - Stock Titan
Published on: 2025-09-26 19:58:52 - newser.com
Lava Therapeutics Nv Azioni (LVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
4.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):